Works matching AU Twamley, Brendan


Results: 121
    1
    2
    4
    5
    6
    7
    8
    9
    10
    11
    12
    13
    14

    Lanthanide complexes of an oxazoline-phenoxide hybrid chelate.

    Published in:
    Canadian Journal of Chemistry, 2005, v. 83, n. 5, p. 449, doi. 10.1139/V05-069
    By:
    • Berg, David J.;
    • Chuanjian Zhou;
    • Barclay, Tosha;
    • Xuening Fei;
    • Shengyu Feng;
    • Ogilvie, Kevin A.;
    • Gossage, Robert A.;
    • Twamley, Brendan;
    • Wood, Mark
    Publication type:
    Article
    15
    16
    17
    18
    19
    20
    21

    Bicyclo[1.1.1]pentane Embedded in Porphyrinoids**.

    Published in:
    Angewandte Chemie, 2023, v. 135, n. 26, p. 1, doi. 10.1002/ange.202302771
    By:
    • Grover, Nitika;
    • Cheveau, Maxime;
    • Twamley, Brendan;
    • Kingsbury, Christopher J.;
    • Mattern, Cornelia M.;
    • Senge, Mathias O.
    Publication type:
    Article
    22
    23
    24
    25
    26
    27
    28
    29
    30
    31
    32
    33
    34

    Synthesis and Biological Evaluation of 1-(Diarylmethyl)-1 H -1,2,4-triazoles and 1-(Diarylmethyl)-1 H -imidazoles as a Novel Class of Anti-Mitotic Agent for Activity in Breast Cancer.

    Published in:
    Pharmaceuticals (14248247), 2021, v. 14, n. 2, p. 169, doi. 10.3390/ph14020169
    By:
    • Ana, Gloria;
    • Kelly, Patrick M.;
    • Malebari, Azizah M.;
    • Noorani, Sara;
    • Nathwani, Seema M.;
    • Twamley, Brendan;
    • Fayne, Darren;
    • O'Boyle, Niamh M.;
    • Zisterer, Daniela M.;
    • Pimentel, Elisangela Flavia;
    • Endringer, Denise Coutinho;
    • Meegan, Mary J.;
    • Fantacuzzi, Marialuigia
    Publication type:
    Article
    35
    36
    37
    39
    40
    41

    Synthesis, analytical characterization, and monoamine transporter activity of the new psychoactive substance 4‐methylphenmetrazine (4‐MPM), with differentiation from its ortho‐ and meta‐ positional isomers.

    Published in:
    Drug Testing & Analysis, 2018, v. 10, n. 9, p. 1404, doi. 10.1002/dta.2396
    By:
    • McLaughlin, Gavin;
    • Baumann, Michael H.;
    • Kavanagh, Pierce V.;
    • Morris, Noreen;
    • Power, John D.;
    • Dowling, Geraldine;
    • Twamley, Brendan;
    • O'Brien, John;
    • Hessman, Gary;
    • Westphal, Folker;
    • Walther, Donna;
    • Brandt, Simon D.
    Publication type:
    Article
    42

    An approach to shortening the timeframe between the emergence of new compounds on the drugs market and the availability of reference standards: The microscale syntheses of nitrazolam and clonazolam for use as reference materials, utilizing polymer‐supported reagents

    Published in:
    Drug Testing & Analysis, 2018, v. 10, n. 7, p. 1198, doi. 10.1002/dta.2383
    By:
    • Dowling, Geraldine;
    • Kavanagh, Pierce V.;
    • Eckhardt, Hans‐Georg;
    • Twamley, Brendan;
    • Hessman, Gary;
    • McLaughlin, Gavin;
    • O'Brien, John;
    • Brandt, Simon D.
    Publication type:
    Article
    43
    44
    45
    46
    47

    Outsmarted by nootropics?

    Published in:
    Drug Testing & Analysis, 2017, v. 9, n. 3, p. 518, doi. 10.1002/dta.2142
    By:
    • Dowling, Geraldine;
    • Kavanagh, Pierce V.;
    • Talbot, Brian;
    • O’Brien, John;
    • Hessman, Gary;
    • McLaughlin, Gavin;
    • Twamley, Brendan;
    • Brandt, Simon D.
    Publication type:
    Article
    48

    Analytical characterization and pharmacological evaluation of the new psychoactive substance 4-fluoromethylphenidate (4F-MPH) and differentiation between the (±)- threo and (±)- erythro diastereomers.

    Published in:
    Drug Testing & Analysis, 2017, v. 9, n. 3, p. 347, doi. 10.1002/dta.2167
    By:
    • McLaughlin, Gavin;
    • Morris, Noreen;
    • Kavanagh, Pierce V.;
    • Power, John D.;
    • Dowling, Geraldine;
    • Twamley, Brendan;
    • O'Brien, John;
    • Hessman, Gary;
    • Murphy, Brian;
    • Walther, Donna;
    • Partilla, John S.;
    • Baumann, Michael H.;
    • Brandt, Simon D.
    Publication type:
    Article
    49
    50